Precision AQ - Investor Relations & External Communications’ Post

Read now in CVIR 📚 Comparison of Clinical Performance Between Two Types of Symmetric-Tip Haemodialysis Catheters: A Single-Centre, Randomized Trial https://lnkd.in/djmaPyjx #IRad

Click here for the full content: https://bit.ly/CT-771565 On Monday, August 14, #2seventybio held its Q2 2023 earnings call (press release: https://bit.ly/44cbqEU) acknowledging #Abecma’s (#BMS / 2seventy’s #BCMA CAR-T) decline in US sales while disclosing updates on the SC-DARIC33’s (drug-regulated #CD33 CAR-T) Ph1 PLAT-08 (https://bit.ly/45cCxkx) clinical hold. Celltelligence provides insights on the causes behind Abecma’s revenue decrease while discussing the potential delay that the clinical hold might cause on #DARIC33 ’s clinical development.

In our analysis of the first data presented during the AIAC congress we found a significant reduction in the duration of the QRS by left bundle branch area pacing in patients with left bundle branch block . We will soon publish data on a larger number of patients and clinical follow-up data. #AIAC2023 #CSP #LBBAP

What impact does treatment with ropeginterferon alfa-2b have on event-free survival in patients with polycythemia vera? Read our latest article on the final data from PROUD-PV and its extension trial CONTINUATION-PV to find out! 👉 https://loom.ly/FA80bes #MPN #MPNsm

Over 77% of Advanced Afib patients had <1% Afib burden over a mean follow-up of 2-3 years in 330 Hybrid Convergent patients. Learn more about achieving long-term Afib burden reduction in Advanced Afib patients at https://bit.ly/2YxDEyc #HybridAFTherapy

Considering a Clinical Trial for IPF?   If you or a loved one are living with #IPF (Idiopathic Pulmonary Fibrosis), you might be exploring every avenue for better treatments and a brighter future. Clinical trials could be the key to unlocking groundbreaking advancements in IPF care.  It's important to weigh the benefits and potential risks and have open discussions with your healthcare provider before selecting a clinical trial as a treatment option. Stay connected with us on our Clinical Trial for patients with IPF by following the link below: https://lnkd.in/gXRNn-3A #IPFAwareness #ClinicalTrials #HopeForIPF

DCRI's Jennifer Rymer and Schuyler Jones, along with former DCRI member Sunil Rao, joined their colleagues at #ACC24 this morning for a deep dive into the ACS toolbox, where they examined guidelines, proven and potential therapies, and opportunities to tailor approaches to each patient's unique characteristics and needs. Jones took the opportunity to reinforce GDMT adherence after ACS and noted 30% of patients still don't receive the Big 5 (aspirin, beta blockers, ACE inhibitors, statins, P2Y12 inhibitors). #clinicaltrials #clinicalresearch #hearthealth #heartdisease

🎉 We are LIVE today at FIVE! Register here: https://ow.ly/vZFN50Qw6eO Some say prediabetes is a controversial diagnostic label lacking both validation and clinical relevance. This webinar will lay out pro and con arguments to debate the existence and clinical value of the prediabetic label. #Webinar #Sysmex #ClinicalConversations #Prediabetes

Did you know? Almac's IXRS®3 IRT platform supports DTP (Direct-to-Patient) workflow management for Decentralised Clinical Trials (DCTs). For rare disease patients who may face limited trial availability and travel challenges, DCTs and DTP shipments offer an opportunity to participate in research for new treatments and therapies. Visit our website to learn more about our direct-to-patient and supply management capabilities. https://okt.to/wgdlnA #raredisease #clinicaltrials #decentralisedtrials

🎉 We are LIVE today at FIVE! Register here: https://ow.ly/f9oa50Qw6gX Some say prediabetes is a controversial diagnostic label lacking both validation and clinical relevance. This webinar will lay out pro and con arguments to debate the existence and clinical value of the prediabetic label. #Webinar #Sysmex #ClinicalConversations #Prediabetes